How Corbus Uses Synthetic Cannabinoids to Fight Diseases – Bloomberg



Bloomberg

How Corbus Uses Synthetic Cannabinoids to Fight Diseases
Bloomberg
Yuval Cohen, Corbus Pharmaceuticals chief executive officer, discusses how the company is combating autoimmune diseases with Bloomberg's Ed Hammond on "Bloomberg Markets: The Close." (Source: Bloomberg) …



Source link

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.